Management of Hyperlipidemia
1. Understand elements of Cardio Metabolic risk reduction.
2. Review the approach to LCL-C lowering therapy as the primary target and approach to non-HDL-C therapy as the secondary target.
3. Determine the indications for advanced lipid evaluation in the practice of medicine. exercise, smoking cessation, and weight loss, to reduce the risk of comorbidities.
View technical requirements (opens in a new window).
View CME credit information (opens in a new window).
View AAFP staff list (opens in a new window).
View disclosures and disclaimers (opens in a new window).
© 2014 American Academy of Family Physicians. Materials/Contents are not to be reproduced, published or distributed, in whole or in part, in any form or medium, without the express written permission of the American Academy of Family Physicians.
Warning: The unauthorized reproduction or distribution of this copyrighted work is illegal. Criminal copyright infringement, including infringement without monetary gain, is investigated by the FBI and is punishable by up to five years in federal prison and a fine of $250,000.
Edward J. Shahady, MD, Clinical Professor Family Medicine, Medical Director, Diabetes Master Clinician Program Florida Academy of Family Physicians, Fernandina Beach, Florida
- 0.75 AAFP prescribed